The Alzheimer's disease-diabetes angle: Inevitable fate of aging or metabolic imbalance limiting successful aging

Journal of Alzheimer's Disease

Volumn 16, Issue 4, 2009, Pages 673-675

  Bierhaus, Angelika ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; EDITORIAL; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; MENTAL DETERIORATION; METABOLIC DISORDER; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; METABOLISM;

AGING; ALZHEIMER DISEASE; DIABETES MELLITUS; HUMANS;

EID: 67649726071     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1023     Document Type: Editorial

References (31)

1. Neumann KF, Rojo L, Navarrete LP, Farias G, Reyes P, Maccioni RB (2008) Insulin resistance and Alzheimer's disease: molecular links & clinical implications. Curr Alzheimer Res 5, 438-447.
2. Milionis HJ, Florentin M, Giannopoulos S (2008) Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? CNS Spectr 13, 606-613.
3. Li L, Holscher C (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56, 384-402. (Pubitemid 350166529)
4. Morse DR (2006) Live longer, live better: lifestyle diseases and their prevention, part 2. Dent Today 25, 100, 102-103.
5. Pasinetti GM, Zhao Z, Qin W, Ho L, Shrishailam Y, Macgrogan D, Ressmann W, Humala N, Liu X, Romero C, Stetka B, Chen L, Ksiezak-Reding H, Wang J (2007) Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. Interdiscip Top Gerontol 35, 159-175.
6. Pope SK, Shue VM, Beck C (2003) Will a healthy lifestyle help prevent Alzheimer's disease? Annu Rev Public Health 24, 111-132.
7. Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33, 1041-1044.
8. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474-481. (Pubitemid 38174565)
9. Pasquier F, Boulogne A, Leys D, Fontaine P (2006) Diabetes mellitus and dementia. Diabetes Metab 32, 403-414.
10. Luchsinger JA (2008) Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol 585, 119-129.
11. Luchsinger JA, Mayeux R (2007) Adiposity and Alzheimer's disease. Curr Alzheimer Res 4, 127-134.
12. Whitmer RA, Gunderson EP, Quesenberry CP, Jr., Zhou J, Yaffe K (2007) Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 4, 103-109. (Pubitemid 46557496)
13. Rader DJ (2007) Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120, S12-18.
14. Hartig W, Stieler J, Boerema AS, Wolf J, Schmidt U, Weissfuss J, Bullmann T, Strijkstra AM, Arendt T (2007) Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur J Neurosci 25, 69-80. (Pubitemid 46096223)
15. Su B, Wang X, Drew KL, Perry G, Smith MA, Zhu X (2008) Physiological regulation of tau phosphorylation during hibernation. J Neurochem 105, 2098-2108. (Pubitemid 351782245)
16. Heininger K (2000) A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. Rev Neurosci 11 Spec No, 213-328.
17. Andrews MT, Russeth KP, Drewes LR, Henry PG (2008) Adaptive mechanisms regulate preferred utilization of ketones in the heart and brain of a hibernating mammal during arousal from torpor. Am J Physiol Regul Integr Comp Physiol, in press.
18. Martin SL (2008) Mammalian hibernation: a naturally reversible model for insulin resistance in man? Diab Vasc Dis Res 5, 76-81.
19. Avila J, Diaz-Nido J (2004) Tangling with hypothermia. Nat Med 10, 460-461.
20. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27, 13635-13648. (Pubitemid 350278272)
21. Adhikari N, Charles N, Lehmann U, Hall JL (2006) Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr Atheroscler Rep 8, 252-260. (Pubitemid 43676330)
22. Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, Pini E, Monti D, Franceschi C (2008) Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 15, 224-240.
23. Heininger K (2002) Aging is a deprivation syndrome driven by a germ-soma conflict. Ageing Res Rev 1, 481-536.
24. Yankner BA, Lu T (2008) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer's disease. J Biol Chem, in press.
25. Su J, Lucchesi PA, Gonzalez-Villalobos RA, Palen DI, Rezk BM, Suzuki Y, Boulares HA, Matrougui K (2008) Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 28, 1432-1438.
26. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37, 586-600. (Pubitemid 28231153)
27. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14, 1521-1528. (Pubitemid 24312209)
28. Schmitt HP (2006) epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis. Med Hypotheses 66, 898-906.
29. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83, 876-886. (Pubitemid 41598688)
30. Yan SF, D'Agati V, Schmidt AM, Ramasamy R (2007) Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med 7, 699-710.
31. Yan SF, Ramasamy R, Schmidt AM (2008) Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4, 285-293. (Pubitemid 351571138)